Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype
about
Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behaviorCloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YYMolecular genetic analysis of a human neuropeptide Y receptor. The human homolog of the murine "Y5" receptor may be a pseudogeneInactivation of a novel neuropeptide Y/peptide YY receptor gene in primate speciesGut-brain peptides in corticostriatal-limbic circuitry and alcohol use disordersBiophysical methods to study ligand-receptor interactions of neuropeptide YMolecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologueExpression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnoverBlockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypesThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe neuropeptide Y Y1 receptor is a somatic receptor on dorsal root ganglion neurons and a postsynaptic receptor on somatostatin dorsal horn neurons.Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist.Distribution of Y-receptors in murine lingual epitheliaPreferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor.BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonistThe ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.NPY receptors as potential targets for anti-obesity drug development.Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia.Therapeutic potential of neuropeptide Y (NPY) receptor ligands.The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained pain.Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function.Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion diseaseNeuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium.Molecular signaling involved in regulating feeding and other motivated behaviors.NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.Neuropeptide Y and neurovascular control in skeletal muscle and skinThe NPY system and its neural and neuroendocrine regulation of bone.Receptors and ionic transporters in nuclear membranes: new targets for therapeutical pharmacological interventions.Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.Novel analogues of neuropeptide Y with a preference for the Y1-receptor.Neuropeptide Y modulates ATP-induced increases in internal calcium via the adenylate cyclase/protein kinase A system in a human neuroblastoma cell lineCloning and expression of a novel neuropeptide Y receptor.How receptor mutagenesis may confirm or confuse receptor classification.Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
P2860
Q24309148-73913A3A-21A6-48F3-84C5-B356D1DA8AA1Q24315908-EB757486-664C-42A7-8FD6-3AA398092FA9Q24316565-91F2AF53-713D-4561-B33C-5A64A8D6F6C9Q24318959-AF81F51E-9B23-4FC6-A205-D93441C85A01Q27014840-7635B2AD-2E6B-412F-ADD8-16EFB5E9D1C1Q28220437-ABCE60B9-F62F-4342-A184-7182E92FCCA9Q28296214-22C467B3-5A2D-4966-AB76-F8301D64E5C5Q28572322-414EB8AE-C725-4F22-9AEC-1E36BB3A860EQ28580596-133BC681-7CDB-41F5-A76A-59898471E31CQ28583085-E2B38E9B-5AE5-4E37-80B1-041407F1737AQ30486707-203C0804-62D4-4E77-A5AE-8EB45B9F113DQ30724596-FB05EC2C-CD85-4C40-B4CA-5B664552A488Q34138869-DF0CBC31-C7A8-4D7E-9429-E9ED03CCD5ADQ34438797-B9C9445F-F693-42FF-AC74-C10F993CD8E8Q35027090-CD3E0E10-50ED-4C59-BFF0-691E685DA9F2Q35042022-7144F489-54E6-4770-82B6-95097A1FF81CQ35045725-D9998E22-B44E-412F-A8EA-1667CD8C2E0CQ35130522-FDC4243F-9883-468E-9C8C-9A11A1F40824Q35961557-1D6050D5-1400-4A8F-832F-D86CC1776DF0Q36088880-ADB0057E-A60F-45CA-A4AE-B51B0B7D712DQ36179783-BAE3F05A-54F3-40EE-B2DB-E819E193E28DQ36602618-4D4AB8B9-3F67-4C35-BAA8-0C4378C3B25CQ36606890-134C8D5C-30D6-4A41-9F85-3974FE1581CBQ36724125-080FBDBB-4B9E-42BB-AD7A-B6F0DB1AD8F4Q36814747-F628EA1D-CD66-4A2B-85CD-0CB32A6745E1Q36829270-5DCAA4F6-757C-40FA-97AF-F6107D9C93FFQ36850591-F3857092-B674-41D1-85F1-3A2B79F04D2FQ37337568-5B76A7E0-3F3E-4B70-980C-13821327DF6BQ38000135-296D422D-5DF6-41E1-99C7-F17487A59104Q38025438-7D793734-5B33-4788-B45D-11FE7B489728Q39509078-85A41B0B-A8D4-4E82-9E7E-201CD35BE613Q40385965-9D0AC054-01A4-43F6-843E-80657C2249F1Q40805267-63FDD538-66E8-46B0-A739-BB8625297C0DQ41134273-7FCB1EA9-B9F2-49D6-A1C0-04FCE287242EQ41185106-7C7F62C7-583E-4751-A481-61F2FCFD7B36Q41501042-473DC9F8-8DC3-446D-9DB0-1F170DEAE9DBQ42485703-8E87D8B8-7A0D-4D8C-9C50-4918A230D2D9Q42581670-8C3161C5-E074-4215-80DE-D2F0ECB65721Q43263299-C35A5DE6-4A8B-4BFA-B24E-27D20F0D66B8Q43674629-F740C83A-8E59-4F9E-BA7D-12A1BCD11C9A
P2860
Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype
description
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1995
@ast
im November 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/11/10)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/11/10)
@nl
наукова стаття, опублікована в листопаді 1995
@uk
name
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@ast
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@en
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@nl
type
label
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@ast
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@en
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@nl
prefLabel
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@ast
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@en
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@nl
P2093
P2860
P356
P1476
Expression cloning and pharmac ...... peptide YY Y2 receptor subtype
@en
P2093
M. W. Walker
P. J. Vaysse
R. L. Weinshank
T. A. Branchek
P2860
P304
26758–26761
P356
10.1074/JBC.270.45.26758
P407
P577
1995-11-10T00:00:00Z